1. Home
  2. CPRX vs AIR Comparison

CPRX vs AIR Comparison

Compare CPRX & AIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • AIR
  • Stock Information
  • Founded
  • CPRX 2002
  • AIR 1951
  • Country
  • CPRX United States
  • AIR United States
  • Employees
  • CPRX N/A
  • AIR N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • AIR Aerospace
  • Sector
  • CPRX Health Care
  • AIR Industrials
  • Exchange
  • CPRX Nasdaq
  • AIR Nasdaq
  • Market Cap
  • CPRX 2.6B
  • AIR 2.4B
  • IPO Year
  • CPRX 2006
  • AIR 1988
  • Fundamental
  • Price
  • CPRX $24.69
  • AIR $57.15
  • Analyst Decision
  • CPRX Strong Buy
  • AIR Strong Buy
  • Analyst Count
  • CPRX 8
  • AIR 5
  • Target Price
  • CPRX $32.50
  • AIR $80.80
  • AVG Volume (30 Days)
  • CPRX 1.5M
  • AIR 316.1K
  • Earning Date
  • CPRX 05-07-2025
  • AIR 03-27-2025
  • Dividend Yield
  • CPRX N/A
  • AIR N/A
  • EPS Growth
  • CPRX 107.94
  • AIR N/A
  • EPS
  • CPRX 1.31
  • AIR N/A
  • Revenue
  • CPRX $491,734,000.00
  • AIR $2,682,500,000.00
  • Revenue This Year
  • CPRX $15.17
  • AIR $20.23
  • Revenue Next Year
  • CPRX $8.28
  • AIR $6.46
  • P/E Ratio
  • CPRX $18.96
  • AIR N/A
  • Revenue Growth
  • CPRX 23.49
  • AIR 21.07
  • 52 Week Low
  • CPRX $14.47
  • AIR $54.71
  • 52 Week High
  • CPRX $26.16
  • AIR $76.34
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 62.78
  • AIR 26.92
  • Support Level
  • CPRX $20.68
  • AIR $66.66
  • Resistance Level
  • CPRX $26.16
  • AIR $70.85
  • Average True Range (ATR)
  • CPRX 0.83
  • AIR 2.24
  • MACD
  • CPRX 0.36
  • AIR -0.47
  • Stochastic Oscillator
  • CPRX 75.21
  • AIR 7.62

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

About AIR AAR Corp.

AAR Corp is engaged in providing products and services to aviation, government, and defense market. It operates in two segments namely Aviation Services and Expeditionary Services. The Aviation Services segment consists of aftermarket support and services businesses that provide spares and maintenance support for aircraft operated by it's commercial and government/defense customers. The Expeditionary Services segment consists of businesses that provide products and services supporting the movement of equipment and personnel by the U.S. Department of Defense, foreign governments, and non-governmental organizations. It generates a majority of its revenue from the Aviation Services Segment.

Share on Social Networks: